Loading clinical trials...
Loading clinical trials...
Evaluation of F-18 Tetrafluoroborate (18F-TFB) PET/CT in Patients With Differentiated Thyroid Cancer
Conditions
Interventions
Computed Tomography
Fluorine F 18 Tetrafluoroborate
+2 more
Locations
1
United States
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Start Date
April 22, 2022
Primary Completion Date
May 1, 2028
Completion Date
May 1, 2028
Last Updated
February 27, 2026
NCT03914300
NCT04061980
NCT02152995
NCT03449108
NCT04544111
NCT06790589
Lead Sponsor
Mayo Clinic
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions